Enhancement of Oncolytic Activity of Newcastle Disease virus Through Combination with Retinoic Acid Against Digestive System Malignancies

被引:0
|
作者
Al-Shammari, Ahmed Majeed [1 ]
Al-Esmaeel, Wafeeq Naser [2 ]
Al Ali, Ali Abd Allateef [3 ]
Hassan, Ayman Ali [1 ]
Ahmed, Aysar A. [1 ]
机构
[1] Mustansiriyah Univ, Iraqi Ctr Canc & Med Genet Res, Expt Therapy, Baghdad, Iraq
[2] Southern Tech Univ, Basra Tech Inst, Basrah, Iraq
[3] Univ Basrah, Educ Coll Pure Sci, Biol, Basrah, Iraq
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
261
引用
收藏
页码:126 / 127
页数:2
相关论文
共 50 条
  • [31] The Oncolytic Activity of Newcastle Disease Virus NDV-HUJ on Chemoresistant Primary Melanoma Cells Is Dependent on the Proapoptotic Activity of the Inhibitor of Apoptosis Protein Livin
    Lazar, Itay
    Yaacov, Barak
    Shiloach, Tamar
    Eliahoo, Elad
    Kadouri, Luna
    Lotem, Michal
    Perlman, Riki
    Zakay-Rones, Zichria
    Panet, Amos
    Ben-Yehuda, Dina
    JOURNAL OF VIROLOGY, 2010, 84 (01) : 639 - 646
  • [32] Enhancement of pathogenicity of Newcastle disease virus by alteration of specific amino acid residues in the surface glycoproteins F and HN
    Roemer-Oberdoerfer, Angela
    Veits, Jutta
    Werner, Ortrud
    Mettenleiter, Thomas C.
    AVIAN DISEASES, 2006, 50 (02) : 259 - 263
  • [33] Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma
    Cinatl, J
    Cinatl, J
    Michaelis, M
    Kabickova, H
    Kotchetkov, R
    Vogel, JU
    Doerr, HW
    Klingebiel, T
    Driever, PH
    CANCER RESEARCH, 2003, 63 (07) : 1508 - 1514
  • [34] α2,6-linked sialic acid serves as a high-affinity receptor for cancer oncolytic virotherapy with Newcastle disease virus
    Li, Qian
    Wei, Ding
    Feng, Fei
    Wang, Xi-Long
    Li, Can
    Chen, Zhi-Nan
    Bian, Huijie
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2017, 143 (11) : 2171 - 2181
  • [35] α2,6-linked sialic acid serves as a high-affinity receptor for cancer oncolytic virotherapy with Newcastle disease virus
    Qian Li
    Ding Wei
    Fei Feng
    Xi-Long Wang
    Can Li
    Zhi-Nan Chen
    Huijie Bian
    Journal of Cancer Research and Clinical Oncology, 2017, 143 : 2171 - 2181
  • [36] Combination of Two Marek's Disease Virus Vectors Shows Effective Vaccination Against Marek's Disease, Infectious Bursal Disease, and Newcastle Disease
    Ishihara, Yukari
    Esaki, Motoyuki
    Saitoh, Shuji
    Yasuda, Atsushi
    AVIAN DISEASES, 2016, 60 (02) : 473 - 479
  • [37] Cell-derived Newcastle disease virus variant with two amino acid substitutions near cleavage site of F shows favorable traits as oncolytic virus
    Huberts, Marco
    de Graaf, J. Frederique
    Groeneveld, Daphne
    van Nieuwkoop, Stefan
    Fouchier, Ron A. M.
    van den Hoogen, Bernadette G.
    MOLECULAR THERAPY ONCOLOGY, 2025, 33 (01):
  • [38] Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment
    Keshavarz, Mohsen
    Ebrahimzadeh, Mir Saeed
    Miri, Seyed Mohammad
    Dianat-Moghadam, Hassan
    Ghorbanhosseini, Seyedeh Sara
    Mohebbi, Seyed Reza
    Keyvani, Hossein
    Ghaemi, Amir
    VIROLOGY JOURNAL, 2020, 17 (01)
  • [39] Importance of retinoic acid-inducible gene I and of receptor for type I interferon for cellular resistance to infection by Newcastle disease virus
    Fournier, Philippe
    Wilden, Holger
    Schirrmacher, Volker
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2012, 40 (01) : 287 - 298
  • [40] Oncolytic Newcastle disease virus induced degradation of YAP through E3 ubiquitin ligase PRKN to exacerbate ferroptosis in tumor cells
    Sun, Yifan
    Tang, Lanlan
    Kan, Xianjin
    Tan, Lei
    Song, Cuiping
    Qiu, Xusheng
    Liao, Ying
    Nair, Venugopal
    Ding, Chan
    Liu, Xiufan
    Sun, Yingjie
    JOURNAL OF VIROLOGY, 2024, 98 (03)